ArticleAnnals of surgical oncology2026
Preliminary Experience of Transurethral Thulium Laser En Bloc Resection of Paraganglioma of the Urinary Bladder.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe use of thulium laser en bloc resection (TmLER) for treating bladder tumor has gained increasing attention in recent years. This study aims to share our preliminary clinical experience with respect to the safety and efficacy of TmLER in treating paraganglioma of the urinary bladder (PUB). PATIENTS AND
methodsThe clinical and pathological data of eight patients with PUB who underwent TmLER under general anesthesia at our urology center between January 2020 and April 2024 were retrospectively collected and analyzed. Detailed documentation was maintained regarding intraoperative blood pressure fluctuations, the incidence of perioperative complications, changes in postoperative catecholamine hormone levels, and tumor recurrence rates.
resultsEight patients successfully underwent TmLER without the need for conversion to conventional transurethral resection. The operation duration ranged from 25 to 37 min, with an average of 28.9 min. During TmLER, systolic blood pressure fluctuated between 8 and 20 mmHg, averaging 13.5 mmHg. No significant perioperative complications were observed. Postoperatively, bladder irrigation was discontinued on average after 18.75 h, and the urinary catheter was removed after 3-5 days. Hospital stays ranged from 4 to 6 days, with an average of 4.91 days. At the 1-month follow-up, there was no significant fluctuation in systolic blood pressure before and after urination, and plasma catecholamine hormone levels had normalized. Furthermore, no tumor recurrence was detected at the 12-month follow-up.
conclusionsFor the treatment of PUB, the TmLER technique can effectively reduce intraoperative bleeding and blood pressure fluctuations, and it is a safe and efficient minimally invasive surgical option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.